275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300
2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170
© 2000-2021. Parexel International Corporation.
275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300
2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170
© 2000-2021. Parexel International Corporation.
Your clinical development has shown strong potential so far and the end goal of launching to market inches closer. As you enter Phases IIb and III, enhanced scrutiny of your fledgling product will inevitably throw up various challenges.
This is the time when your decision to partner with us proves most fruitful, as our experienced consultants dig deep into their extensive knowledge and deploy the resources that fit your needs – sharp strategies to steady the course, clinical logistics to implement trials swiftly and the regulatory knowledge to avoid the obstacles which could lead to extra risks, delays, and costs.
Because our Regulatory & Access experts are plugged into the realities of clinical development, their technical insights – regulatory, pricing and reimbursement, patient access – are geared towards more practical, actionable solutions that can be integrated into your Parexel development programs. It’s the difference between ideas that are nice in theory, and those that are effective in practice.
No matter what this phase throws at you, we’ll be at your side, as invested in and excited by your potential new treatment as you are.
2020 Pediatric Perceptions & Insights Study
View Now
Making rare disease drug development personal
View Now
Bringing clinical trials to patients with the decentralized model
View Now
Genomics & biomarkers: Answers in the blood
Watch Now
Decentralized Clinical Trials and Patient Needs
Watch Now
Using sensor technology to deploy Decentralized Clinical Trials and improve patient care
Read Now
Innnovating for the Future of Drug Development
View Now
Parexel FSP Culture Map
View Now
Rise of FSP Outsourcing article
View Now
COVID-19 The Great Decentralized Clinical Trials Accelerator
View Now
2020 Pediatric Perceptions & Insights Study
View Now
Making rare disease drug development personal
View Now
Bringing clinical trials to patients with the decentralized model
View Now
Genomics & biomarkers: Answers in the blood
Watch Now
Decentralized Clinical Trials and Patient Needs
Watch Now
Using sensor technology to deploy Decentralized Clinical Trials and improve patient care
Read Now
Innnovating for the Future of Drug Development
View Now
Parexel FSP Culture Map
View Now
Rise of FSP Outsourcing article
View Now
COVID-19 The Great Decentralized Clinical Trials Accelerator
View Now
Decentralized Clinical Trials brochure
View Now
A multi-pronged and customized approach to rare disease clinical trial patient identification and recruitment
View Now
Parexel FSP: Highly skilled people, where and when you need them
Watch Now
Getting real-world data into clinical research
View Now
EMWA Regulatory Matters Vol 29 Issue 1 March 2020 - J Wolfe and S Takidar
View Now
Q&A: Site and Patient Engagement
View Now
Successful wearable device selection within the clinical trials industry
View Now
Case study: A specialized team for a complex biostatistics challenge
View Now
Industry Perspectives on Decentralized Clinical Trials
View Now
Q&A: The Evolving Role of Technology in Clinical Trials
View Now
APAC RWD and RWE Article
View Now
FSP Infographic
View Now
Patient Sensors Solution Factsheet
View Now
The Evolution of FSP Article
View Now
FSP Case Study: Urgent medical writing need to assist with dual FDA submissions
View Now
Patient registries: Defining the patient
Watch Now
Innovation: Today’s patients, tomorrow’s medicines
Watch Now
Patient registries: Defining the patient
Watch Now
We are always available for a conversation.